Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Lenabasum for Diffuse Cutaneous Systemic Sclerosis	Lenabasum (JBT-101)	Systemic sclerosis	Dermatology , Respiratory System	2018	View \| Download
Lenacapavir with optimised background regimen for treating multidrug resistant human immunodeficiency virus (HIV)-1 infection in people aged 12 years and older	Lenacapavir (GS-6207)	HIV-1 infection	Infectious Disease	2022	View \| Download
Lenadogene Nolparvovec (GS-010) for Vision Loss from Leber's Hereditary Optic Neuropathy Due to Mutation of the ND4 Gene	Lenadogene nolparvovec (Lumevoq; GS-010)	Leber's hereditary optic neuropathy (LHON)	Genetic Disorders , Ophthalmology	2017	View \| Download
Lenalidomide (Revlimid) + rituximab for relapsed/refractory follicular lymphoma and marginal zone lymphoma	Lenalidomide (Revlimid) , Rituximab (MabThera; Rituxan; RG 105)	Follicular lymphoma , Marginal zone lymphoma (MZL)	Haematological Cancer and Lymphomas	2017	View \| Download
Lenalidomide (Revlimid) for Newly Diagnosed Multiple Myeloma – First Line	Lenalidomide (Revlimid)	Multiple myeloma (MM)	Haematological Cancer and Lymphomas	2017	View \| Download
Lenalidomide (Revlimid) in combination with rituximab for untreated follicular lymphoma	Lenalidomide (Revlimid) , Rituximab (MabThera; Rituxan; RG 105)	Follicular lymphoma	Haematological Cancer and Lymphomas	2017	View \| Download
Lenalidomide in addition to R-CHOP chemotherapy for diffuse large B-cell lymphoma	Lenalidomide (Revlimid) , R-CHOP	Diffuse large B-cell lymphoma (DLBCL)	Haematological Cancer and Lymphomas	2019	View \| Download
Leniolisib for previously untreated activated phosphoinositide 3-kinase delta syndrome	Leniolisib	Activated PI3K delta syndrome	Genetic Disorders	2022	View \| Download
Lenti‐D for adrenoleukodystrophy in boys	Elivaldogene tavalentivec (Lenti-D)	Adrenoleukodystrophy (ALD)	Genetic Disorders , Neurology	2017	View \| Download
Lenvatinib and pembrolizumab with transarterial chemoembolisation for treating hepatocellular carcinoma	Lenvatinib (Kisplyx; E7080; lenvatinib mesilate) , Pembrolizumab (Keytruda; MK-3475)	Hepatocellular carcinoma (HCC)	Gastrointestinal Cancer	2022	View \| Download